These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3898831)

  • 21. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.
    Verbeeck RK; Kanfer I; Walker RB
    Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic substitution of antihypertensive drugs: does it affect adherence?
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the bioavailability and bioequivalence of generic medications.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What makes a generic medication generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2009 Dec; 47(12):17-20. PubMed ID: 20000278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of generic ophthalmic drugs.
    Novack GD
    Ocul Surf; 2013 Jan; 11(1):54-6. PubMed ID: 23321360
    [No Abstract]   [Full Text] [Related]  

  • 26. Liability of pharmacists for substitution of a generic drug for its brand-name counterpart.
    Hirsh HL
    Med Law; 1987; 6(4):293-302. PubMed ID: 3613889
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of differences in state drug product selection laws on pharmacists' substitution behavior.
    Carroll NV; Fincham JE; Cox FM
    Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs.
    Darrow JJ; Chong JE; Kesselheim AS
    BMJ; 2020 Jun; 369():m2236. PubMed ID: 32576554
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulatory status of medicinal products for human beings in the European Union. The role of generic products.
    Minghetti P
    Pharmacol Res; 1996; 34(1-2):3-7. PubMed ID: 8981548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 32. Economic aspects of drug substitution.
    Salehi H; Schweitzer SO
    Health Care Financ Rev; 1985; 6(3):59-68. PubMed ID: 10311162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 34. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy.
    Simmons HE
    Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic inequivalence.
    Rheinstein PH
    Drug Saf; 1990; 5 Suppl 1():114-9. PubMed ID: 2182054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are drugs within a class interchangeable?
    Furberg CD; Herrington DM; Psaty BM
    Lancet; 1999 Oct; 354(9185):1202-4. PubMed ID: 10513728
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of comparative performance of orally inhaled drug products in view of the classical bioequivalence paradigms: an analysis of the current scientific and regulatory dilemmas of inhaler evaluation.
    Horhota ST
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):408-13. PubMed ID: 25237840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution.
    Madian AG; Panigrahi A; Perera MA; Pinto N
    BMC Pharmacol Toxicol; 2014 Dec; 15():69. PubMed ID: 25472557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling and simulation of biopharmaceutical performance.
    Zhang X; Lionberger RA
    Clin Pharmacol Ther; 2014 May; 95(5):480-2. PubMed ID: 24747237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generic bioequivalence: a scientific consensus needed.
    Am Fam Physician; 1987 Feb; 35(2):91, 95. PubMed ID: 3812175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.